Prostate Cancer Recruiting Phase 2 Trials for Talazoparib (DB11760)

Also known as: Prostatic Cancer / Prostatic neoplasms malignant / Carcinoma Prostate / Cancer Of Prostate / Malignant Neoplasm of Prostate / Prostate Cancers / Prostate carcinoma / Carcinoma of the prostate / Cancer, Prostate / Carcinoma of prostate / Prostatic carcinoma / Carcinoma prostatic / Ca prostate / Prostate cancer NOS

IndicationStatusPhase
DBCOND0062462 (Prostate Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03148795A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate CancerTreatment